Author

C. Havnar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. A. Lo· 2 shared A. Wallace· 2 shared D. Oreper· 2 shared N. Lounsbury· 2 shared X. Pechuan-Jorge· 2 shared A. McKay· 1 shared A. S. Shaw· 1 shared B. Korin· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. A. Lo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The renal capsule, a vibrant and adaptive cell environment of the kidney in homeostasis and aging

B. Korin, S. Avraham, R. Moncada, T. Ho, M. C. Tleugabulova, H. Menon, S. Darmanis, Y. Liang, Z. Modrusan, C. Chalouni, C. Victoria, L. Rangell, C. Havnar, W. Ewart, C. Jones, , A. S. Shaw

This study characterizes the renal capsule's cellular composition and dynamics in health, aging, and disease, revealing its adaptive responses and age-related changes.

bioRxiv · May 11, 2023 · PreprintImmunology

Origins and timing of emerging lesions in advanced renal cell carcinoma

A. Wallace, S. Porten, A. A. Lo, D. Oreper, N. Lounsbury, C. Havnar, X. Pechuan-Jorge, O. Zill, M. Meng

This study uses multi-region sequencing to analyze the origins and timing of tumor lesions in advanced renal cell carcinoma, finding that metastases often emerge early and VTT forms later through inflammatory processes.

bioRxiv · Jun 27, 2021Cancer Biology

Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies

A. A. Lo, A. Wallace, D. Oreper, N. Lounsbury, C. Havnar, X. Pechuan-Jorge, T. D. Wu, R. Bourgon, R. Jones, K. Krogh, G.-Y. Yang, O. A. Zill

The paper analyzes tumor evolution across cancer types to identify factors affecting neoantigen targeting in immunotherapy.

bioRxiv · Mar 15, 2021Cancer Biology